About Xenocor
Xenocor is a company based in Salt Lake City (United States) founded in 2000. Xenocor has raised $10 million across 3 funding rounds from investors including GenHenn Capital, Patel Family Investments and Mountain Pacific Venture Partners. Xenocor offers products and services including Saberscope and HD Image Optimizer. Xenocor operates in a competitive market with competitors including Olympus, SurgiQuest, Eximis Surgical, New View Surgical and Genicon, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xenocor
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Unspecified
Mar 21, 2023
-
Investors
GenHenn Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xenocor
Xenocor offers a comprehensive portfolio of products and services, including Saberscope and HD Image Optimizer.
Provides single-use HD camera for enhanced laparoscopic visualization and safety.
Replaces traditional systems for plug-and-play surgical monitoring.
People of Xenocor
Unlock access to complete
Unlock access to complete
Funding Insights of Xenocor
Xenocor has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $10 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xenocor
Xenocor has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include GenHenn Capital, Patel Family Investments and Mountain Pacific Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Xenocor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xenocor
Investment portfolio details for Xenocor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xenocor
Detailed financials for Xenocor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xenocor Comparisons
Peer comparison for Xenocor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xenocor
Xenocor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, SurgiQuest, Eximis Surgical, New View Surgical and Genicon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Products for minimally invasive surgery are developed and supplied.
|
|
| Locked | Locked | Locked |
Minimal invasive specimen removal tools
|
|
| Locked | Locked | Locked |
Minimally invasive systems for laparoscopic surgery are developed.
|
|
| Locked | Locked | Locked |
Patented laparoscopic instruments are designed, manufactured, and distributed.
|
Detailed competitors of Xenocor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xenocor
Complete news archive for Xenocor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xenocor
Xenocor was founded in 2000 and raised its 1st funding round 20 years after it was founded.
Xenocor is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Ashok Khandkar is the current CEO of Xenocor.
Xenocor is a funded company, having raised a total of $10M across 3 funding rounds to date.
Xenocor was founded in 2000 and is headquartered in Salt Lake City, United States. Operations focus on the medical device sector, where sterile, single-use laparoscopic scopes are developed for minimally invasive surgeries. The Xenoscope device, cleared under FDA 510(k) K171344, enables high-definition real-time imaging and supports procedures in remote or power-limited environments. Multi-purpose functionality is emphasized for surgical versatility.
Xenocor's top competitors include Olympus, New View Surgical and SurgiQuest.
Xenocor offers Saberscope and HD Image Optimizer.
Xenocor has 3 investors. Key investors include GenHenn Capital, Patel Family Investments, and Mountain Pacific Venture Partners.